IE
ORPH

Israel Englander’s Orphazyme A/S ORPH Stock Holding History

Israel Englander’s Portfolio ORPH Stock Details ORPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33,928
Closed -$139K – 7712
2021
Q3 		$139K Buy
+33,928
New +$175K ﹤0.01% 6284
2021
Q2 		– Sell
-122,114
Closed -$1.02M – 7377
2021
Q1 		$1.02M Sell
122,114
-11,422
-9% -$141K ﹤0.01% 4208
2020
Q4 		$1.42M Sell
133,536
-64,020
-32% -$653K ﹤0.01% 3487
2020
Q3 		$2.04K Buy
+197,556
New +$1.98M ﹤0.01% 2582

Other funds holding ORPH

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $3.64B AUM 83.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Israel Englander's ORPH Position: Q4 2021 in Review

Israel Englander sold out of Orphazyme A/S (ORPH) in Q4 2021, closing a stake of 33,928 shares — an estimated $139K sold.

Israel Englander first reported a position in ORPH in Q3 2020 and held it in 4 quarters. The position peaked at $1.42M in Q4 2020. 20 funds tracked by Wall St. Rank hold ORPH as of Q4 2021.

  • Israel Englander reported no remaining Orphazyme A/S position as of Q4 2021 after selling out during the quarter.
  • Israel Englander sold 33,928 Orphazyme A/S shares in Q4 2021, an estimated $139K.
  • Israel Englander first reported a position in Orphazyme A/S in Q3 2020 and held it in 4 quarters.
  • Israel Englander's Orphazyme A/S position peaked at $1.42M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Orphazyme A/S as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.